LOQ HAIR LAUNCH - From Lashes to Locks: Expanding Your Patient Value Experience
Join us for an exclusive session designed for aesthetic practitioners looking to expand their services with hair restoration solutions. Discover how the LOQ Hair range can seamlessly integrate into your clinic to meet growing patient demand and boost revenue—without the burden of large inventory investments.
Key Takeaways:
Why Hair Restoration Matters: Understand why both men and women need effective hair loss solutions.
Patient Crossover Opportunities: Explore the link between injectable patients and hair/GLP blockers.
Inside the LOQ Product Journey: Learn how LOQ started with lash & brow innovations and evolved into a full hair restoration line.
Innovative Treatment Options: See how hair mists and capsules fill treatment gaps while minimizing side effects.
Revenue Boosting Strategies: Discover profitable add-ons for injectable clinics without stock overhead.
Speaker - Mike Clague, Aesthetic Nurse, BSC, Australia
Mike began his career in medical aesthetics with Allergan, the makers of anti-wrinkle injections and fillers, being educated on techniques from some of the best injectors globally throughout a six-year period. Mike worked with Dr Mauricio De Maio, Dr Michael Kane, Dr Ava Shamban, Dr Mary Lupo, Dr Alastair Carruthers, Dr Jean Carruthers, Dr Herve Respaldo, Dr Steven Liew, Professor Greg Goodman and many more talented ‘OG’ doctors. Basically, he learned from the best of the best.
Mike’s first qualification was his BSC majoring in anatomy at Monash University. In this course, Mike gained a vast insight into human anatomy and physiology through comprehensive theoretical work, and in practice by performing many dissections of cadavers.
In the past 21 years, Mike has trained over 6000 doctors and nurses in the art of injecting both muscle relaxants and dermal fillers across the USA, Australia, New Zealand, Thailand, India, Malaysia and the Philippines in addition to consulting for such well-esteemed companies as Allergan Pharmaceuticals, ALMA lasers, Lutronic, Galderma Pharmaceuticals, FILL MED Art Filler, HUGEL aesthetics, Xytide and Croma Pharmaceuticals Austria. Mike has performed over 40,000 injectable treatments.
Mike is published in 10 peer reviewed medical journals. Recently a consensus on the management of delayed onset nodules.
The most notable of his publications was the first reversal of blindness caused by dermal filler by injecting hyaluronidase deeply into the supra-orbital notch . Notably, this is now accepted as the gold standard for hyaluronic acid dissolving in a visual disturbance event after many other repeated cases vs the inferior retrobulbar injection.
In terms of his practice, Mike is passionate about natural, undetectable results for all of his patients, placing great importance on safe realistic and reliable outcomes